Cargando…
Clinical characteristics and risk factors for the isolation of multi-drug-resistant Gram-negative bacteria from critically ill patients with COVID-19
BACKGROUND: We investigated the clinical characteristics and risk factors for the isolation of multi-drug-resistant (MDR) Gram-negative bacteria (GNB) from critically ill COVID-19 patients. METHODS: We retrospectively matched (1:2) critical COVID-19 patients with one or more MDR GNB from any clinica...
Autores principales: | Baiou, A., Elbuzidi, A.A., Bakdach, D., Zaqout, A., Alarbi, K.M., Bintaher, A.A., Ali, M.M.B., Elarabi, A.M., Ali, G.A.M., Daghfal, J., Almaslamani, M.A., Ibrahim, A.S.S., Alkhal, A., Omrani, A.S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Healthcare Infection Society. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7866848/ https://www.ncbi.nlm.nih.gov/pubmed/33561503 http://dx.doi.org/10.1016/j.jhin.2021.01.027 |
Ejemplares similares
-
Convalescent plasma for the treatment of patients with severe coronavirus disease 2019: A preliminary report
por: Omrani, Ali S., et al.
Publicado: (2020) -
The initial impact of a national BNT162b2 mRNA COVID-19 vaccine rollout
por: Zaqout, Ahmed, et al.
Publicado: (2021) -
The first consecutive 5000 patients with Coronavirus Disease 2019 from Qatar; a nation-wide cohort study
por: Omrani, Ali S., et al.
Publicado: (2020) -
Remdesivir for patients with Coronavirus disease 2019 pneumonia requiring high oxygen support
por: Alibrahim, Rim S., et al.
Publicado: (2022) -
Effectiveness of the neutralizing antibody sotrovimab among high-risk patients with mild-to-moderate SARS-CoV-2 in Qatar
por: Zaqout, Ahmed, et al.
Publicado: (2022)